Article
Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.
European urology - 1 Nov 2016
Collazo-Lorduy Ana, Castillo-Martin Mireia, Wang Li, Patel Vaibhav, Iyer Gopa, Jordan Emmet, Al-Ahmadie Hikmat, Leonard Issa, Oh William K, Zhu Jun, McBride Russell B, Cordon-Cardo Carlos, Solit David B, Sfakianos John P, Galsky Matthew D
Abstract excerpt
Metastatic urachal carcinoma is a rare, understudied, and aggressive malignancy with limited treatment options. Histologically, urachal carcinomas resemble enteric adenocarcinomas and anecdotally respond to systemic therapies utilized in colorectal cancer. Targeted exome sequencing of archival primary tumor tissue from a patient with metastatic urachal cancer revealed EGFR amplification and wild-type KRAS. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
